Back to top
more

Rockwell Medical (RMTI)

(Delayed Data from NSDQ)

$0.97 USD

0.97
137,770

-0.03 (-3.39%)

Updated Aug 6, 2025 04:00 PM ET

After-Market: $0.96 -0.01 (-0.62%) 7:58 PM ET

Zacks Rank:

This is our short term rating system that serves as a timeliness indicator for stocks over the next 1 to 3 months. How good is it? See rankings and related performance below.

Zacks Rank Definition Annualized Return
1Strong Buy23.75%
2Buy17.82%
3Hold9.58%
4Sell5.28%
5Strong Sell2.61%
S&P50011.30%

Zacks Rank Education - Learn about the Zacks Rank

Zacks Rank Home - Zacks Rank resources in one place

Zacks Premium - The only way to fully access the Zacks Rank

4-Sell of 5       4  

Style Scores:

The Style Scores are a complementary set of indicators to use alongside the Zacks Rank. It allows the user to better focus on the stocks that are the best fit for his or her personal trading style.

The scores are based on the trading styles of Value, Growth, and Momentum. There's also a VGM Score ('V' for Value, 'G' for Growth and 'M' for Momentum), which combines the weighted average of the individual style scores into one score.

  • Value Score A
  • Growth Score A
  • Momentum Score A
  • VGM Score A

Within each Score, stocks are graded into five groups: A, B, C, D and F. As you might remember from your school days, an A, is better than a B; a B is better than a C; a C is better than a D; and a D is better than an F.

As an investor, you want to buy stocks with the highest probability of success. That means you want to buy stocks with a Zacks Rank #1 or #2, Strong Buy or Buy, which also has a Score of an A or a B in your personal trading style.

Zacks Style Scores Education - Learn more about the Zacks Style Scores

B Value F Growth D Momentum D VGM

Industry Rank:

The Zacks Industry Rank assigns a rating to each of the 265 X (Expanded) Industries based on their average Zacks Rank.

An industry with a larger percentage of Zacks Rank #1's and #2's will have a better average Zacks Rank than one with a larger percentage of Zacks Rank #4's and #5's.

The industry with the best average Zacks Rank would be considered the top industry (1 out of 265), which would place it in the top 1% of Zacks Ranked Industries. The industry with the worst average Zacks Rank (265 out of 265) would place in the bottom 1%.

Zacks Rank Education -- Learn more about the Zacks Rank
Zacks Industry Rank Education -- Learn more about the Zacks Industry Rank

Bottom 40% (148 out of 246)

Industry: Medical - Products

Zacks Premium FeatureView All Zacks #1 Ranked Stocks

Zacks News

Zacks Equity Research

Maravai LifeSciences Holdings, Inc. (MRVI) Tops Q1 Earnings and Revenue Estimates

by Zacks Equity Research

Maravai LifeSciences Holdings, Inc. (MRVI) delivered earnings and revenue surprises of 25.58% and 6.35%, respectively, for the quarter ended March 2022. Do the numbers hold clues to what lies ahead for the stock?

Zacks Equity Research

Lantheus Holdings (LNTH) Beats Q1 Earnings and Revenue Estimates

by Zacks Equity Research

Lantheus Holdings (LNTH) delivered earnings and revenue surprises of 110.87% and 26.26%, respectively, for the quarter ended March 2022. Do the numbers hold clues to what lies ahead for the stock?

Zacks Equity Research

Quanterix Corporation (QTRX) Reports Q4 Loss, Tops Revenue Estimates

by Zacks Equity Research

Quanterix Corporation (QTRX) delivered earnings and revenue surprises of 20.29% and 1.08%, respectively, for the quarter ended December 2021. Do the numbers hold clues to what lies ahead for the stock?

Zacks Equity Research

Rockwell Medical (RMTI) Reports Q3 Loss, Misses Revenue Estimates

by Zacks Equity Research

Rockwell Medical (RMTI) delivered earnings and revenue surprises of -14.29% and -11.47%, respectively, for the quarter ended September 2021. Do the numbers hold clues to what lies ahead for the stock?

Zacks Equity Research

Will Rockwell Medical (RMTI) Report Negative Q3 Earnings? What You Should Know

by Zacks Equity Research

Rockwell Medical (RMTI) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

Zacks Equity Research

Rockwell Medical (RMTI) Reports Q2 Loss, Misses Revenue Estimates

by Zacks Equity Research

Rockwell Medical (RMTI) delivered earnings and revenue surprises of -12.50% and -11.64%, respectively, for the quarter ended June 2021. Do the numbers hold clues to what lies ahead for the stock?

Zacks Equity Research

Rockwell Medical (RMTI) May Report Negative Earnings: Know the Trend Ahead of Next Week's Release

by Zacks Equity Research

Rockwell Medical (RMTI) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

Zacks Equity Research

Moving Average Crossover Alert: Rockwell Medical (RMTI)

by Zacks Equity Research

Rockwell Medical (RMTI) could be a stock to avoid from a technical perspective, as the firm is seeing unfavorable trends on the moving average crossover front

Zacks Equity Research

Rockwell Medical (RMTI) Reports Q4 Loss, Lags Revenue Estimates

by Zacks Equity Research

Rockwell Medical (RMTI) delivered earnings and revenue surprises of -12.50% and -5.34%, respectively, for the quarter ended December 2020. Do the numbers hold clues to what lies ahead for the stock?

Zacks Equity Research

Rockwell Medical (RMTI) May Report Negative Earnings: Know the Trend Ahead of Next Week's Release

by Zacks Equity Research

Rockwell Medical (RMTI) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

Zacks Equity Research

Do Options Traders Know Something About Rockwell Medical (RMTI) Stock We Don't?

by Zacks Equity Research

Investors need to pay close attention to Rockwell Medical (RMTI) stock based on the movements in the options market lately.

Zacks Equity Research

Will Rockwell Medical (RMTI) Report Negative Q4 Earnings? What You Should Know

by Zacks Equity Research

Rockwell Medical (RMTI) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

Zacks Equity Research

Rockwell Medical (RMTI) Reports Q3 Loss, Misses Revenue Estimates

by Zacks Equity Research

Rockwell Medical (RMTI) delivered earnings and revenue surprises of -42.86% and -12.18%, respectively, for the quarter ended September 2020. Do the numbers hold clues to what lies ahead for the stock?

Zacks Equity Research

Rockwell Medical (RMTI) May Report Negative Earnings: Know the Trend Ahead of Next Week's Release

by Zacks Equity Research

Rockwell Medical (RMTI) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

Zacks Equity Research

Rockwell Medical (RMTI) Soars: Stock Adds 9.7% in Session

by Zacks Equity Research

Rockwell Medical (RMTI) saw a big move last session, as its shares jumped nearly 10% on the day, amid huge volumes.

Zacks Equity Research

Company News for Sep 11, 2020

by Zacks Equity Research

Companies in the news are: VRTU, OSTK, KLR, RMTI

Zacks Equity Research

Rockwell Medical (RMTI) Reports Q2 Loss, Tops Revenue Estimates

by Zacks Equity Research

Rockwell Medical (RMTI) delivered earnings and revenue surprises of 23.08% and 0.61%, respectively, for the quarter ended June 2020. Do the numbers hold clues to what lies ahead for the stock?

Zacks Equity Research

Rockwell Medical (RMTI) Reports Q1 Loss, Tops Revenue Estimates

by Zacks Equity Research

Rockwell Medical (RMTI) delivered earnings and revenue surprises of 0.00% and 0.96%, respectively, for the quarter ended March 2020. Do the numbers hold clues to what lies ahead for the stock?

Zacks Equity Research

Will Rockwell Medical (RMTI) Report Negative Q1 Earnings? What You Should Know

by Zacks Equity Research

Rockwell Medical (RMTI) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

Zacks Equity Research

Rockwell Medical (RMTI) Reports Q4 Loss, Misses Revenue Estimates

by Zacks Equity Research

Rockwell Medical (RMTI) delivered earnings and revenue surprises of 8.33% and -6.47%, respectively, for the quarter ended December 2019. Do the numbers hold clues to what lies ahead for the stock?

Zacks Equity Research

Rockwell Medical (RMTI) May Report Negative Earnings: Know the Trend Ahead of Next Week's Release

by Zacks Equity Research

Rockwell Medical (RMTI) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

Zacks Equity Research

Rockwell Medical (RMTI) Reports Q3 Loss, Tops Revenue Estimates

by Zacks Equity Research

Rockwell Medical (RMTI) delivered earnings and revenue surprises of 20.00% and 0.05%, respectively, for the quarter ended September 2019. Do the numbers hold clues to what lies ahead for the stock?

Zacks Equity Research

Analysts Estimate Rockwell Medical (RMTI) to Report a Decline in Earnings: What to Look Out for

by Zacks Equity Research

Rockwell Medical (RMTI) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

Zacks Equity Research

Rockwell Medical (RMTI) Reports Q2 Loss, Lags Revenue Estimates

by Zacks Equity Research

Rockwell Medical (RMTI) delivered earnings and revenue surprises of -12.50% and -9.59%, respectively, for the quarter ended June 2019. Do the numbers hold clues to what lies ahead for the stock?

Zacks Equity Research

Analysts Estimate Rockwell Medical (RMTI) to Report a Decline in Earnings: What to Look Out for

by Zacks Equity Research

Rockwell Medical (RMTI) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.